Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

From stem cells to cancer: balancing immortality and neoplasia

Oncogene volume 23, pages 5092–5094 (2004)Cite this article

Abstract

In this issue of Oncogene, Serakinci et al show that adult stem cells can be targets for neoplastic transformation. After transducing human adult mesenchymal stem cells (hMSC) with the telomerase hTERT gene, and growing them for many population doublings in culture, Serakinci et al observed that the transduced cells developed characteristics consistent with transformation including loss of contact inhibition, anchorage independence and tumour formation in mice. Underlying these changes were alterations to genes involved in cell cycle regulation and senescence as well as oncogene activation. The importance of these observations is twofold. Firstly, showing that stem cells can become tumours raises a note of caution for stem cell therapeutics. Secondly, the findings lend support to the stem cell hypothesis of cancer development, and provide an experimental system in which the tantalizing hint of new diagnostic, prognostic, and therapeutic opportunities offered by this concept can be explored further.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  • Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF . (2003). Proc. Natl. Acad. Sci. USA, 100, 3983–3988.

  • Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI . (2003). Proc. Natl. Acad. Sci. USA, 100, 15178–15183.

  • Marx J . (2003). Science, 301, 1308–1310.

  • Passegue E, Jamieson CH, Ailles LE and Weissman IL . (2003). Proc. Natl. Acad. Sci. USA, 100 (Suppl 1), 11842–11849.

  • Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R and Wright NA . (2003). Mol. Pathol., 56, 86–96.

  • Serakinci N, Guldberg P, Burns J, Abdallah B, Schrødder H, Jensen T and Kassem M . (2004). Oncogene, in press.

  • Shi S, Gronthos S, Chen S, Reddi A, Counter CM, Robey PG and Wang CY . (2002). Nat. Biotechnol., 20, 587–591.

  • Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG and Kassem M . (2002). Nat. Biotechnol., 20, 592–596.

  • Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB . (2003). Cancer Res., 63, 5821–5828.

  • Tuan RS, Boland G and Tuli R . (2003). Arthritis Res. Ther., 5, 32–45.

  • Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF and Martens UM . (2003). Leukemia, 17, 1146–1149.

Download references

Author information

Authors and Affiliations

  1. Centre for Oncology & Applied Pharmacology, Cancer Research UK Beatson Laboratories, University of Glasgow, Garscube Estate, Switchback Rd., Glasgow, G61 1BD, UK

    W Nicol Keith

Authors
  1. W Nicol Keith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Nicol Keith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keith, W. From stem cells to cancer: balancing immortality and neoplasia. Oncogene 23, 5092–5094 (2004). https://doi.org/10.1038/sj.onc.1207762

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207762

Keywords

This article is cited by

Search

Advanced search

Quick links